Novartis Oncology Budget Analyst Salaries in Boulder | Comparably
At Novartis Oncology, we are passionate about the discovery and development of innovative medicines. read more
EMPLOYEE
PARTICIPANTS
14
TOTAL
RATINGS
161

Novartis Oncology Budget Analyst Salaries in Boulder

The average Novartis Oncology Budget Analyst in Boulder earns an estimated $83,046 annually. Novartis Oncology's Budget Analyst compensation is $15,121 more than the US average for a Budget Analyst.

In Boulder, The Finance Department at Novartis Oncology earns $4,829 more on average than the Operations Department.

Last updated 3 years ago.

$35k
$45k
$53k
$62k
$96k
$135k
$158k
$83,046
Average Compensation
$83,046
avg. base

Budget Analyst Salaries at Novartis Oncology

In Boulder, Budget Analysts earn $5,047 more than Business Analysts, and $7,234 less than Senior Accountants.

Accounting Manager
$96k*
Senior Accountant
$90k*
Business Analyst
$78k*
Financial Analyst
$77k*
Accountant
$69k*
* estimated salary

Compensation at Novartis Oncology by Department

In Boulder, The Finance Department averages $4,829 more than the Operations Department, and $16,534 less than the Sales Department

Sales
$92,112 Avg. total comp.
+$17k
Finance
$75,578 Avg. total comp.
Operations
$70,749 Avg. total comp.
-$5k

Budget Analyst Compensation by Gender (All Companies)

The average female Budget Analyst at companies similar size to Novartis Oncology reported making $98,833, while the average male Budget Analyst at similar sized companies reported making $76,324.

Budget Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Budget Analyst at companies similar size to Novartis Oncology reported making $101,500, while the average African American/Black Budget Analyst at similar sized companies reported making $70,000.

How Budget Analysts at Novartis Oncology Rate Their Compensation

The majority of Budget Analysts at Novartis Oncology believe they're not compensated fairly. 100% of Budget Analysts at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology

×
Rate your company